Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Feb 2026 for Keros Therapeutics, Inc., €65k. Read the official filing
Filing timeline
BuySaleKeith Regnante
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Keith Regnante: trading record in brief
Keith Regnante is a declared insider of Keros Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 8 June 2023 and the latest from 18 February 2026.
Sales make up the whole of the open-market record (1 sale, €65k). Besides market trades, the filings include 1 share grant and 3 option exercises. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 20 February 2026: an open-market sale of €65k, in Keros Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Keith Regnante
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,739 shares@ US$16.356.8% of flowCommon StockSEC:0001682068-26-000003:0
44,000 shares0Common StockSEC:0001415889-25-004597:0
40,000 shares@ US$16.0039.4% of flowCommon StockSEC:0001415889-25-002024:0
40,000 shares@ US$16.0062.5% of flowCommon StockSEC:0001209191-24-001155:0
20,000 shares@ US$16.0030.8% of flowCommon StockSEC:0001209191-23-036261:0
5 of 5 declarations
